Literature DB >> 3897128

Flunarizine, a calcium entry blocker in migraine prophylaxis.

W K Amery, L I Caers, T J Aerts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897128     DOI: 10.1111/j.1526-4610.1985.hed2505249.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  7 in total

1.  Calcium entry blocker: treatment in acute pain in cluster headache patients.

Authors:  A Boiardi; M Gemma; E Porta; C Peccarisi; G Bussone
Journal:  Ital J Neurol Sci       Date:  1986-10

Review 2.  Strategies for diagnosing and managing medication-induced headache.

Authors:  J G Edmeads; M J Gawel; J Vickers
Journal:  Can Fam Physician       Date:  1997-07       Impact factor: 3.275

3.  [Drug treatment as migraine prophylaxis.].

Authors:  H C Diener; A Ziegler
Journal:  Schmerz       Date:  1989-12       Impact factor: 1.107

4.  [Problems in and approaches to the design and evaluation of therapeutic studies in patients with headache.].

Authors:  W D Gerber; D Soyka; U Niederberger; G Haag
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

Review 5.  Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

6.  Factors Associated with Favorable Outcome of Topiramate Migraine Prophylaxis in Pediatric Patients.

Authors:  Il Han Yoo; WooJoong Kim; Hunmin Kim; Byung Chan Lim; Hee Hwang; Jong Hee Chae; Jieun Choi; Ki Joong Kim
Journal:  J Clin Neurol       Date:  2017-07       Impact factor: 3.077

7.  In Silico Repositioning of Dopamine Modulators with Possible Application to Schizophrenia: Pharmacophore Mapping, Molecular Docking and Molecular Dynamics Analysis.

Authors:  Melissa Mejia-Gutierrez; Bryan D Vásquez-Paz; Leonardo Fierro; Julio R Maza
Journal:  ACS Omega       Date:  2021-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.